Insurance Stopped Covering Ozempic? Why It Happened and What to Do Next

If your insurance stopped covering Ozempic, get the exact reason from your pharmacy or plan first, then match it to why you take it. For type 2 diabetes, check for an expired approval, missing records, or a drug-list change. For weight loss only, check whether the plan excludes that use or requires diabetes.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Tell your prescriber today when your next dose is due. If you have type 2 diabetes and meet the program's terms, NovoCare Pharmacy charges $349 for the Ozempic 0.25/0.5 mg pen or 1 mg pen, or $499 for the 2 mg pen. NovoCare uses a one-pen, 28-day billing unit; the starter pen covers six weeks under the label's starting schedule.

Here's the catch most people miss: the words on your rejection decide everything. The table below turns those words into the one thing to ask for.

RX Index Decision Verdict: Get the written reason first, then match the fix to why you take Ozempic, before you pay for anything new.

• Best for: Adults whose plan paid for Ozempic before and now rejects a refill, or charges a lot more.
• Not ideal for: People checking coverage before starting. See whether insurance covers Ozempic before you start.
• The factor that matters most: The written denial reason and the rule that applies to your diagnosis and exact product.

Jump to cash prices

What should I do first if insurance stopped covering Ozempic?

Find out whether the pharmacy claim was rejected, or covered with a much bigger bill for you. If it was rejected, ask for the exact reason and any written denial. An expired approval, a diagnosis rule, a drug-list change, and a plan-wide exclusion each need a different fix.

A few words you'll see, in plain English:

• Prior authorization (PA): a permission slip from your insurer. The plan has to say yes before it pays. Ask how long the approval lasts.
• Formulary: your plan's list of covered drugs.
• Step therapy: a rule that you try another drug first unless an exception applies.
• Diagnosis code: the code your doctor uses to tell the plan why you take a drug.
• PBM (pharmacy benefit manager): the company that runs your drug benefit, like CVS Caremark, Express Scripts, or OptumRx.

Start with why you take Ozempic

Ozempic is FDA-approved for adults with type 2 diabetes. The pen is also approved to lower heart and kidney risks in certain adults with type 2 diabetes, and the tablets to lower heart risk in some. Neither form is approved for weight loss (Ozempic pen label; Ozempic tablet label). That's why plans treat these two readers so differently.

Match what you were told to the right request

This table points you to the right request. It isn't a ruling on your claim. Only your plan's written decision is. Ask about the exact form you use, too; do not assume coverage of a pen means coverage of a tablet. The request types follow HealthCare.gov's prescription guidance and the plan-specific rules below. If the plan covered it but the bill is high, see how Ozempic costs work with insurance. Got a code instead of words? See GLP-1 pharmacy rejection codes explained.

Prefer to click instead of read? Pick your answers below.

Want to see it in action? Say you're 54, you've had type 2 diabetes for eight years, and you just started a new job. Your first Ozempic refill on the new plan gets rejected: "prior authorization required." That's the first row. Your new plan has never seen your diabetes history, so your prescriber's office sends a fresh request with your diagnosis and records. If you meet the cash program's terms and need one fill while it's processed, the 1 mg pen is $349 at NovoCare Pharmacy. (That's a made-up example, not a real reader.)

The right next step isn't the same for everyone. It depends on your diagnosis, your plan and its drug list, your state, your budget, whether you prefer an injection or a pill, and whether you're considering FDA-approved or compounded treatment. The RX Index's Find My GLP-1 Path tool is free, takes about 2 minutes, and needs no signup. Answer a few quick questions and see the GLP-1 paths and providers that fit your goals, budget, insurance, and situation. It won't tell you whether your plan will pay. Only your plan can.

See which GLP-1 path fits you

What should I ask my pharmacy, plan, and prescriber?

Ask the pharmacy or plan to name the problem and the exact request that fixes it. Give your prescriber that answer and the date your supply runs out. Ask for a plan in case there's a gap, rather than changing how you take the medicine yourself.

Script for your pharmacy or plan

Call the drug-benefit number on your insurance card. Read this, or paste it into a message:

My plan paid for Ozempic before, but this refill was rejected or costs much more. My prescription is Ozempic [pen or tablet] at [strength on my label]. What is the exact rejection reason and code? Is this an expired approval, a denied renewal, missing records, a step-therapy rule, a drug-list change, an exclusion, or a covered claim with a higher cost to me? What request fixes it, who sends it, and where? If there's a denial, please send the written notice, the rule you used, and the deadline to appeal. Is a temporary or transition fill available under my plan? Can I have a reference number?

Message for your prescriber

Send this through your patient portal or the office's usual secure message:

My Ozempic refill has a coverage problem. My supply runs out around [date], and my last dose was [date]. The plan says [exact reason], reference [number]. It needs [request or records] by [deadline, or "not known yet"]. Can your team send the right request, including my original diabetes diagnosis records if needed? If there might be a gap, what's my plan before my next dose? If I can't get Ozempic, what's my plan to keep my blood sugar controlled?

Write down who you talked to, the date, the reference number, and what they promised. A written answer beats a phone promise every time.

Keep a refill record in your own notes. Copy these labels and fill them in privately: product and strength; prescribed use; last paid fill; supply-runs-out date; plan and drug-benefit type; rejection reason; old approval's end date; request needed; records needed; person responsible; filing deadline; expected decision date; submission address; reference number; follow-up date. Write "not known yet" for anything missing, then ask the plan or prescriber to fill that gap. This page does not collect or save the record.

One safety note. If you have type 2 diabetes, don't stop or change your diabetes medicines without a plan from your prescriber. Contact your clinician promptly about strong thirst, peeing a lot, or blurry vision. Confusion or loss of consciousness needs emergency care—call 911 (MedlinePlus: high blood sugar; diabetes emergencies).

Don't stretch, skip, or space out doses to make a pen last longer. The Ozempic label has specific missed-dose instructions, and your prescriber decides how you restart.

The records to gather

You don't need every record for every request. Ask your plan which ones it wants.

Why did my insurance stop covering Ozempic?

Ozempic coverage can stop because of a diabetes-diagnosis rule, an expired approval, a drug-list or step-therapy change, a weight-loss exclusion, or a whole new plan. The examples below show how specific plans handle these rules. Your written notice says which cause applies to you.

Here's what that looks like in real plan and employer notices:

• A diagnosis check. California's Medicaid drug program, Medi-Cal Rx, applies a type 2 diabetes diagnosis restriction to Ozempic claims; claims that don't meet it receive Reject Code 80. Since January 1, 2026, weight-loss use is excluded for members 21 and older. Requests for members under 21 can still be reviewed for medical necessity under the federal EPSDT benefit, which provides screening and treatment services for children and young adults. The notice also allows review of non-weight-loss uses for medical necessity (Medi-Cal Rx notice, December 12, 2025; updated April 6, 2026).
• Weight-loss cuts that reach Ozempic. Idaho's state employee plan ended coverage of all weight-loss drugs on November 1, 2025, including off-label use. Ozempic for diabetes stayed covered (Boise State employee notice, September 2025).
• Diabetes coverage kept while weight-loss coverage goes. Blue Cross Blue Shield of Massachusetts said it would keep covering Ozempic and other GLP-1s for type 2 diabetes on plans that dropped GLP-1s for obesity (BCBSMA provider notice).
• Approvals based on claims history. UnitedHealthcare's 2026 commercial policy says it may approve Ozempic based on your past claims and medicine history (UHC policy 2026 P 1332-8, effective July 1, 2026). If you've switched plans, ask whether the new plan needs diagnosis records.

For plan-specific drug-list details, our pages on Express Scripts and OptumRx explain what to check. Your employer's benefit choices still matter. See which employers have changed GLP-1 coverage, and the difference between a plan exclusion and a prior authorization denial.

Can I get coverage back if I have type 2 diabetes?

Sometimes. A renewal, corrected records, or a formulary exception may restore coverage. Type 2 diabetes matches an approved use of Ozempic, but a diagnosis alone doesn't guarantee your plan will pay. Match the records and request to the exact reason for the denial.

What if my approval expired?

A prior authorization lasts for the period the plan approves—12 months in the two published policies below. When it ends, the plan may need a new permission slip, even if nothing about you changed. Ask whether the plan needs a renewal or a brand-new request. A new plan may require its own approval.

For the difference between a first approval and a renewal, see initial vs. renewal prior authorization.

What if my A1C improved?

A better A1C (a measure of your average blood sugar) doesn't explain a denial by itself. In fact, some renewal rules ask for exactly that kind of improvement. Check whether the plan got your diagnosis history and judged the request by its renewal rules.

Two real policies show why old records matter:

These are two examples, not rules for every UnitedHealthcare or Blue Cross plan. Your plan's current policy is the one that counts. More detail: UnitedHealthcare's Ozempic authorization requirements and Blue Cross Ozempic prior authorization.

Say you've taken Ozempic for two years, your A1C dropped from 8.4 to 6.6, and your renewal comes back "criteria not met." Those numbers alone don't explain the denial. Ask whether the request included your original diagnosis records and was judged under the correct renewal rules. (Hypothetical example.)

What if my plan wants a different drug?

If your plan moved Ozempic off its list or wants you to try another drug first, you have two paths. Ask for a formulary exception if Ozempic is the right fit for medical reasons, or ask your prescriber whether the drug your plan prefers would work for you. Switching is your prescriber's call. For step-therapy rules, see how to get past step therapy.

Insurer-specific guides: CVS Caremark, Aetna.

What if I was taking Ozempic for weight loss?

If you take Ozempic only for weight loss, coverage depends on your plan's diagnosis rules and benefits. Ozempic isn't FDA-approved for weight loss. If the plan excludes that use, medical need alone doesn't add the benefit, but you can ask whether the rule was applied correctly. Also ask whether your plan covers a medicine that is approved for weight management.

No web page, including this one, can make a plan pay for a use it excludes. A new provider can't either. Here's what you can still do:

• Ask your plan: "Do you cover Wegovy, Zepbound, the Wegovy pill, or Foundayo for weight management? What are the rules?"
• Know the family tie. Wegovy and Ozempic both contain semaglutide, but their products, doses, and approved uses differ. Wegovy has a weight-management indication. Whether to switch, and at what dose, is your prescriber's decision. See Ozempic vs. Wegovy and switching from Ozempic to Wegovy.
• Know the cash catch. NovoCare's terms say its Ozempic cash program is only for Ozempic prescribed for an FDA-approved use (NovoCare Pharmacy terms). If your clinician prescribes Wegovy and you meet its program terms, its standard self-pay prices are $349 per box of 4 standard-dose pens, $399 per box of 4 Wegovy HD 7.2 mg pens, and $149 to $299 for 30 Wegovy tablets, as of October 21, 2026. The $149 tablet price is for the 1.5 mg starting strength; the labeled 25 mg maintenance strength costs $299 per 30 tablets (Wegovy label).
• Keep billing honest. The diagnosis on a claim has to be your real diagnosis. Plans can check your claims history.
• Ask your employer. Some employers add weight-loss coverage as an extra. See how to ask your employer to cover GLP-1s, and Ozempic coverage for prediabetes if that's your situation.

Which appeal rules apply to my insurance?

Use the process for the plan that actually covers your drugs. A correction, a renewal, an exception, and an appeal are four different requests. The time you have to file an appeal is different from the time the plan has to answer.

Three things people miss:

• Medicare exceptions run on their own clock. Asking Part D to cover a nonformulary drug or waive a rule can require an exception request. For a request for benefits, the plan's clock (72 hours standard, 24 hours expedited) starts once it gets your prescriber's supporting statement (CMS).
• Medicaid managed care may keep paying during an appeal, with conditions. You must ask for it by the later of 10 days after the notice is sent or the date the change takes effect, and your old approval can't have run out. Ask the plan whether all continuation conditions apply to you. If you lose the appeal, you may have to pay back the cost (42 CFR 438.420).
• Check how a plan-wide exclusion applies. You can ask whether the rule was applied to you correctly. Medical need alone doesn't add a benefit the plan excludes.

Ask your prescriber about a peer-to-peer review, a doctor-to-doctor call with the plan. For the full process, see how to appeal a GLP-1 denial. If your notice calls for a formal appeal, you can prepare a GLP-1 appeal letter with your prescriber's records.

Did my plan have to warn me?

Sometimes. Employer plans under ERISA generally must send a summary of a major benefit cut within 60 days after it's adopted; a qualifying regular notice system can use intervals of up to 90 days (29 CFR 2520.104b-3). A material change outside renewal that affects the Summary of Benefits and Coverage generally needs 60 days' notice before it takes effect (29 CFR 2590.715-2715). Ask HR for your plan document, the change notice, and whether a one-time transition fill is available.

Does Medicare still cover Ozempic?

Medicare Part D can cover Ozempic for type 2 diabetes and its approved heart and kidney uses. The standard Part D benefit excludes weight-loss-only use; some plans offer supplemental coverage. The $50 Medicare GLP-1 Bridge does not include Ozempic. It covers Wegovy, the Zepbound KwikPen, and Foundayo for eligible weight-management patients.

What CMS says about the Bridge, in plain words (CMS provider FAQ, updated August 6, 2026):

• People with type 2 diabetes must seek GLP-1 coverage through their regular Part D plan, not the Bridge, even if that plan denies coverage. CMS may check Medicare records to confirm a diabetes diagnosis.
• If your Part D plan paid for any GLP-1 for you in 2026, you can't use the Bridge in 2026 (CMS Part D FAQ). CMS hasn't yet said how far back it will look in 2027.

Do this now. Medicare Open Enrollment runs October 15 to December 7. Changes start January 1 (Medicare.gov). If you take Ozempic for diabetes, check your plan's 2027 drug list for the exact form you use before December 7.

Sources: Medicare.gov's Part D costs for the 2026 and 2027 limits; CMS for the negotiated price. The $274 is CMS's summary negotiated price for a 30-day supply of the grouped semaglutide products. Package-specific prices differ. It isn't your copay or a cash offer you can claim at the pharmacy. Certain payments made on your behalf also count toward the Part D out-of-pocket threshold.

The $25 savings card doesn't work with Medicare. NovoCare Pharmacy lets Medicare members pay cash outside their plan, but that spending doesn't count toward the yearly limit. More detail: does Medicare cover Ozempic and the Medicare GLP-1 Bridge.

Does Medicaid still cover Ozempic?

It depends on your state's drug benefit and the reason for the prescription. California's Medi-Cal Rx example above shows why a weight-loss exclusion and a diabetes-coverage rule must be read separately, including the review available for members under 21. Read your state's or plan's notice and use the appeal steps above if you disagree.

See GLP-1 Medicaid coverage by state. Ro doesn't accept Medicaid members for its program.

What could my next Ozempic refill cost?

Your next cost depends on whether insurance pays, whether a savings offer applies, and whether you meet a cash program's rules. As of October 21, 2026, NovoCare Pharmacy charges $349 for the Ozempic 0.25/0.5 mg pen or 1 mg pen, $499 for the 2 mg pen, and $149 to $299 for 30 Ozempic tablets. These are medicine-only prices for FDA-approved uses, subject to the program's terms.

Source: NovoCare Pharmacy terms and savings-offer terms, checked October 21, 2026. NovoCare defines its pen price by a one-pen, 28-day program unit; the starter pen covers six weeks under the label's starting schedule. At an unchanged maintenance strength, 13 pens cover 52 weeks (364 days), and 12 tablet bottles cover 360 days. These are ongoing medicine-only figures, not a first-year estimate or a full bill. The tablet label allows 4 mg as a maintenance strength and says the 1.5 mg starting strength is not effective for blood sugar control (tablet label), so don't plan your ongoing budget around $149.

Read the fine print before you count on a number:

• FDA-approved uses only. NovoCare's Ozempic cash program and savings offer require Ozempic prescribed for an FDA-approved use.
• Cash doesn't count toward your deductible. NovoCare's terms say you can't send these purchases to insurance or count them toward your deductible or out-of-pocket limit.
• The $199 price is narrow. It covers at most the first two qualifying fills of the 0.25/0.5 mg pen. For NovoCare Pharmacy, new means you've never filled an Ozempic injection through NovoCare or NovoCare Legacy. The prescription must be written and received by December 31, 2026, and shipped by January 31, 2027. At a participating retail pharmacy, you must be new to the Ozempic Savings Offer, with no participation in a prior offer in the past 365 days; redeem it and fill the prescription by December 31, 2026. Prior treatment alone doesn't decide this; your use of the offer or pharmacy matters.
• Unknown fees aren't $0. Ask your prescriber's office about visit or lab fees.
• HSA and FSA. NovoCare Pharmacy says it accepts HSA/FSA cards, with free delivery (NovoCare Pharmacy). Confirm your account's rules.

Your current prescriber can send the prescription to NovoCare Pharmacy, whether you're new or already taking Ozempic. Before choosing a cash fill, check NovoCare Pharmacy's eligibility and prices for yourself.

Can a savings card or patient assistance help?

A commercial copay card, a cash program, and patient assistance each have different rules. A denial doesn't make you eligible for all three. Start with the row that matches your insurance.

Sources: savings-offer terms; NovoCare Pharmacy terms; patient assistance eligibility, checked October 21, 2026. If you're uninsured, check Ozempic patient assistance eligibility before you pay cash. More on the card: how the Ozempic savings card works.

The savings-card terms treat FEHB, Marketplace, and state employee plans as commercial insurance. Other government programs, including Medicare, Medicaid, and VA benefits, are excluded from the copay offer.

If even the cash price is out of reach, tell your prescriber your real monthly limit. That gives them a real budget to work with.

Would a different provider or medicine help?

Your current prescriber is the right first call. A new provider can't make an excluded use covered. A new provider is worth considering if your doctor doesn't handle the paperwork or offer ongoing GLP-1 care. A new clinician must still decide what treatment fits.

If you're under 18, pregnant or planning a pregnancy, have type 1 diabetes, have a history of an eating disorder, or have a condition the label lists as a reason not to use the drug, talk with your own clinician before choosing any program.

If your current doctor won't prescribe a weight-management medicine, a telehealth prescriber can review whether one is appropriate. Ro is one option. Ro says its cash prices for FDA-approved weight-management medicines match NovoCare, LillyDirect, and TrumpRx; its membership is a separate charge (Ro pricing). If your own doctor will write the prescription and you meet the manufacturer's program terms, you can skip the membership and order from the manufacturer's pharmacy directly.

Ro's options page shows membership costs and links to medication pricing. Open Pricing there to compare medicine costs.

See Ro's prices for FDA-approved weight-loss medicine

When does Ro's coverage check fit?

Ro offers a free coverage report for the Ozempic pen, Wegovy pen, and Zepbound pen. It fits adults with commercial insurance, or FEHB (the Federal Employees Health Benefits program), who want a report on coverage and authorization rules. The free check doesn't submit treatment requests or write prescriptions. The report isn't an approval or an urgent refill service.

The honest limits (Ro checker; Ro's Ozempic page):

• It checks pens only. Ro says it can't check the Wegovy pill, Foundayo, or the Zepbound KwikPen, and it doesn't list Ozempic tablets.
• It asks for your insurance card details, unlike our no-signup tool.
• It can't fix exclusions. Ro prescribes Ozempic for weight loss only if its provider thinks that's appropriate, and that doesn't change your plan's diagnosis rule.
• Government coverage has limits. Ro can't coordinate drug coverage for Medicare, Medicaid, or other government plans apart from FEHB. Medicaid members can't join its program (Ro insurance).
• Paid care is separate from the free check. Get started for $39, then as low as $74/month with annual plan paid upfront ($888 for 12 months). The month-to-month plan is $149 a month. Medicine is billed separately. The $39 is refunded if you're not eligible for GLP-1s (Ro pricing).

If you want a separate coverage report for your Ozempic pen and are open to ongoing care through Ro, the free checker is a reasonable place to start. For your existing prescription's renewal, call your current doctor's office first.

Check Ozempic pen coverage with Ro

More on what Ro's insurance help includes.

Is compounded semaglutide a replacement for lost coverage?

No, not in the way people hope. Compounded semaglutide is not Ozempic, not a generic, and not FDA-approved, and the FDA doesn't review compounded drugs for safety, effectiveness, or quality before they reach patients (FDA safety page). Since the semaglutide shortage ended, FDA rules limit pharmacies from making copies of approved drugs.

What the FDA has said (FDA compounding update, April 1, 2026 update, checked October 21):

• The semaglutide shortage was declared over on February 21, 2025.
• A traditional compounding pharmacy operating under section 503A generally can't regularly make what are essentially copies of a commercially available drug. A prescriber can document a change that makes a significant difference for a specific patient under that rule.
• For 503B outsourcing facilities, use of bulk drug ingredients requires a listing on the FDA's 503B bulk-substances list or its shortage list. Semaglutide is on neither list.

Losing insurance doesn't, by itself, make a compounded prescription appropriate. Ozempic's studies do not establish the safety or effectiveness of a particular compounded product. Read whether compounded GLP-1s are still available first.

If your clinician identifies a medical need that an FDA-approved medicine cannot meet and recommends considering a compounded medicine for weight management, Embody is one cash-pay option. It advertises compounded semaglutide injections at $69 a month with no separate membership fee, and plans of 4, 12, 24, or 52 weeks priced at checkout (Embody).

The $69 price has a commitment. Embody's written terms put that rate on a 12-month bundle, or $828 at the listed rate. The monthly plan is $79. The terms say doses, shipping, and provider visits are included. You pay at checkout before the clinician decides whether to prescribe.

You must cancel at least 72 hours before your next billing date. Payments already made aren't refundable except when the provider finds you medically ineligible; that refund covers the unused part of the term after deducting services already provided (refund policy). We couldn't confirm the amount due today through our link. Before paying, check the plan length, the total, renewal terms, the pharmacy, and whether it serves your state. Our Embody review goes deeper.

See Embody's current pricing

What we actually verified

On October 21, 2026, we read the sources linked on this page and built the tables from them. Those checks show what the sources say. They don't confirm your benefits, your pharmacy claim, your eligibility, or your final bill.

We didn't see your plan's decision, call an insurer, or test any provider. Learn how our methodology works.

More questions about lost Ozempic coverage

Can my insurance stop covering Ozempic even if I have type 2 diabetes?

Yes. Plans change drug lists, approvals expire, and new plans can require their own approval. A renewal, the right records, or an exception may restore payment if it meets your plan's rules. Ask for the written reason first.

Is there any way to get Ozempic covered again?

Sometimes. A corrected claim, a renewed approval, an exception, or an appeal can restore payment, and the right one depends on why coverage stopped. Get that reason before paying a new provider to fight it for you.

What if I can't afford hundreds of dollars a month?

Tell your prescriber your real budget and ask about a covered option on your plan. If you're uninsured with lower income, check Novo Nordisk's patient assistance rules. A cash discount can lower a price without making it affordable, so check the full cost before signing up for any membership.

Why did my insurance stop covering Ozempic for weight loss?

Ozempic is FDA-approved for type 2 diabetes, not weight loss. Some plan policies require a diabetes diagnosis for Ozempic or exclude weight-loss drugs, as the examples above show. Ask whether your plan covers a medicine approved for weight management instead.

How much is Ozempic without insurance right now?

As of October 21, 2026, NovoCare Pharmacy's standard price is $349 for the 0.25/0.5 mg pen or 1 mg pen and $499 for the 2 mg pen, under its one-pen, 28-day program unit. The starter pen covers six weeks under the label's starting schedule. Ozempic tablets cost $149 for 30 tablets at the starting 1.5 mg strength, $199 at 4 mg, or $299 at 9 mg. These prices require an FDA-approved use and program eligibility, and don't count toward your deductible.

Can I still use the $25 Ozempic savings card?

Only if your commercial insurance still covers Ozempic and you meet the offer's terms. The card saves up to $100 per 28-day pen fill and can't make an uncovered refill $25. Medicare and Medicaid are excluded; the terms treat FEHB, Marketplace, and state employee plans as commercial coverage.

Can my A1C be too good to keep coverage?

You need the actual denial reason to know. Some published renewal rules ask for blood sugar that improved or stayed stable, which counts in your favor. Ask whether the plan used renewal rules and got your original diagnosis records.

Does a much higher pharmacy bill mean my coverage ended?

Not always. A claim can be covered while a new deductible, a higher tier, or a savings card limit raises your share. Ask the pharmacy and plan to show what the plan paid and what you owe.

Does the $50 Medicare program cover Ozempic?

No. The Medicare GLP-1 Bridge covers Wegovy, the Zepbound KwikPen, and Foundayo for eligible weight-management patients. People with type 2 diabetes must seek GLP-1 coverage through their regular Part D plan, subject to that plan's rules.

What if I miss doses while this gets sorted out?

Tell your prescriber the date of your last dose and when your supply runs out. The label has specific missed-dose instructions, and your prescriber decides how you restart. Don't change your dose on your own.

Is compounded semaglutide the same as Ozempic?

No. Compounded semaglutide is not FDA-approved, and the FDA doesn't review it for safety, effectiveness, or quality before it reaches patients. Ozempic's studies do not establish the safety or effectiveness of a particular compounded product.

Sources

Checked October 21, 2026, unless noted. Separate policy, update, and revision dates are shown.

• Novo Nordisk, Ozempic (injection) prescribing information (revised May 2026)
• Novo Nordisk, Ozempic tablets prescribing information (revised January 2026)
• Novo Nordisk, Wegovy prescribing information
• NovoCare, Pharmacy terms and conditions
• NovoCare, Diabetes savings offer terms
• NovoCare, Ozempic pharmacy page
• NovoCare, Patient Assistance Program
• UnitedHealthcare, Diabetes Medications – GLP-1 policy 2026 P 1332-8 (effective July 1, 2026)
• Blue Cross Blue Shield Federal Employee Program, Policy 5.30.086 (effective July 1, 2026)
• Medi-Cal Rx, GLP-1 coverage considerations (December 12, 2025; effective January 1, 2026; updated April 6, 2026)
• Boise State University, State insurance to end weight loss drug coverage (September 11, 2025)
• Blue Cross Blue Shield of Massachusetts, GLP-1 medications for obesity: coverage update
• eCFR, 29 CFR 2560.503-1: claims procedures
• HealthCare.gov, Prescription medications
• HealthCare.gov, Internal appeals
• Medicare.gov, Appeals in a Medicare drug plan
• CMS, Part D exceptions
• eCFR, 42 CFR 438.402 and 42 CFR 438.420
• eCFR, 29 CFR 2520.104b-3 and 29 CFR 2590.715-2715
• CMS, Medicare GLP-1 Bridge: Information for Providers and Information for Part D Plans (both updated August 6, 2026)
• Medicare.gov, Open Enrollment
• CMS, Negotiated prices for 2027 fact sheet
• Medicare.gov, Part D costs
• Ro, Pricing, Insurance checker, Insurance, and Ozempic
• Embody, Homepage, Terms & Conditions (last updated April 24, 2026), and Cancellation & Refund Policy (last updated August 25, 2026)
• FDA, Policies for compounders as GLP-1 supply stabilizes (April 1, 2026 update)
• FDA, Concerns with unapproved GLP-1 drugs used for weight loss
• MedlinePlus, High blood sugar and diabetic hyperglycemic hyperosmolar syndrome

Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.